CHIP: A Response to the Infant Victims of the Opioid Epidemic: Neonatal Abstinence Syndrome (NAS) Care Resource Toolkit

California Health Care Improvement Projects (CHIPs) are designed by CHCF Health Care Leadership Program participants with the goal of addressing meaningful challenges or opportunities in health care. 

Background: Substance abuse by pregnant women is a public health crisis. In, 2019, the U.S. was in the grips of an epidemic, with >70,000 opioid drug overdoses. In 2020 ED visits for opioid abuse went up 45% and studies have estimated an almost 30% increase in opioid overdoses. This has resulted in an ever-increasing number of babies struggling with highly traumatic abstinence (NIDA).

Problem: 40 percent of pregnant women use substances like alcohol, cigarettes, opiates, meth, and/or marijuana. At least 15 percent of women use illicit substances during pregnancy, with opioids and methamphetamine being the primary drugs of choice in California. Medical care costs for infants with NAS are 9 times higher. NAS affects vital functions that permit growth and normalcy; sleep, eating, and elimination. The impact of long-term outcomes of NAS on neurodevelopment is strongly related to the caregiving environment. There are limited if any resources specific to caregivers of infants suffering from NAS.

Goal: The NAS CARE Resource Kit will provide support to parents/caregivers and providers of substance-exposed infants. With attuned caregiving, it is possible to ameliorate infant outcomes & reduce medical and social welfare costs.

Outcome Objective: To bring awareness, education, and skills to parents/caregivers of substance-affected newborns. To promote caregiver capability and stability and decrease the pain/suffering of these infants and, thus increasing the likelihood that they will have a better outcome in life (developmentally& socially).

 

Download PDF File